Your browser doesn't support javascript.
loading
Differences in CSF Biomarkers Profile of Patients with Parkinson's Disease Treated with MAO-B Inhibitors in Add-On.
Zenuni, Henri; Candelise, Niccolò; Grillo, Piergiorgio; Simonetta, Clara; Bovenzi, Roberta; Ferri, Alberto; Valle, Cristiana; Mercuri, Nicola Biagio; Schirinzi, Tommaso.
Afiliación
  • Zenuni H; Unit of Neurology, Department of Systems Medicine, University of Roma Tor Vergata, 00133 Rome, Italy.
  • Candelise N; Department of Experimental Medicine, University of Roma La Sapienza, 00185 Rome, Italy.
  • Grillo P; IRCCS Fondazione Santa Lucia, 00179 Rome, Italy.
  • Simonetta C; Unit of Neurology, Department of Systems Medicine, University of Roma Tor Vergata, 00133 Rome, Italy.
  • Bovenzi R; Unit of Neurology, Department of Systems Medicine, University of Roma Tor Vergata, 00133 Rome, Italy.
  • Ferri A; Unit of Neurology, Department of Systems Medicine, University of Roma Tor Vergata, 00133 Rome, Italy.
  • Valle C; IRCCS Fondazione Santa Lucia, 00179 Rome, Italy.
  • Mercuri NB; Institute of Translational Pharmacology (IFT), Consiglio Nazionale delle Ricerche (CNR), 00185 Rome, Italy.
  • Schirinzi T; IRCCS Fondazione Santa Lucia, 00179 Rome, Italy.
J Integr Neurosci ; 21(6): 165, 2022 Oct 08.
Article en En | MEDLINE | ID: mdl-36424753
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Inhibidores de la Monoaminooxidasa Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Integr Neurosci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Inhibidores de la Monoaminooxidasa Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Integr Neurosci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia